Abstract Objective To determine the effect and the patterns of failure in extensive small cell lung cancer (SCLC) patients treated with thoracic intensive modified radiotherapy (IMRT). Methods A retrospective review was conducted on 130 extensive stage SCLC patients received thoracic IMRT from January 2007 to December 2012.Most patients received initial chemotherapy with carboplatin plus etoposide or chemotherapy with cisplatin plus etoposide and 35 patients received PCI.The median thoracic radiation dose was 56 Gy (3267 Gy) with 1823 Gy per fractions. The KaplanMeirer and logrank test, Cox regression were used for survival analysis and to identify prognostic factors.
Zhang Wenjue,Zhou Zongmei,Chen Dongfu et al. Clinical outcomes of extensive stage small cell lung cancer patients treated with intensive modified radiotherapy[J]. Chinese Journal of Radiation Oncology, 2016, 25(1): 14-17.
Zhang Wenjue,Zhou Zongmei,Chen Dongfu et al. Clinical outcomes of extensive stage small cell lung cancer patients treated with intensive modified radiotherapy[J]. Chinese Journal of Radiation Oncology, 2016, 25(1): 14-17.
[1]van Meerbeeck JP,Fennell DA,De Ruysscher DKM.Small-cell lung cancer[J].Lancet,2011,378(9804):1741-1755.DOI:10.1016/s0140-6736(11)60165-7. [2]Slotman B,Faivre-Finn C,Kramer G,et al. Prophylactic cranial irradiation in extensive small-cell lung cancer[J].New Engl J Med,2007,357(7):664-672.DOI:10.1056/NEJMoa071780. [3]Zhu H,Zhou Z,Wang Y,et al. Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis[J].Cancer,2011,117(23):5423-31.DOI:10.1002/cncr.26206. [4]张文珏,周宗玫,陈东福,等.广泛期小细胞肺癌化疗后PCI及颅外病变放疗的Ⅱ期临床研究[J].中华放射肿瘤学杂志,2013,22(5):365-368.DOI:10.3760/cma.j.issn.1004-4221.2013.05.007. Zhang WJ,Zhou ZM,Chen DF,et al. Clinical effect of thoracic radiotherapy and prophylactic cranial irradiation in patients with stage ⅠV small cell lung cancer after chemotherapy:a phase Ⅱ trial[J].Chin J Radiat Oncol,2013,22(5):365-368.DOI:10.3760/cma.j.issn.1004-4221.2013.05.007. [5]Goldstraw P,Crowley J,Chansky K,et al. The IASLC lung cancer staging project:proposals for the revision of the tnm stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours[J].J Thorac Oncol,2007,2(8):706-14.DOI:10.1097/JTO.0b013e31812f3c1a. [6]Eisenhauer EA,Therasse P,Bogaerts J,et al. New response evaluation criteria in solid tumours:revised RECIST guideline (version 1.1)[J].Euro J Cancer,2009,45(2):228-247.DOI:10.1016/j.ejca.2008.10.026. [7]Tas F,Aydiner A,Topuz E,et al. Factors influencing the distribution of metastases and survival in extensive disease small cell lung cancer[J].Acta Oncologica (Stockholm,Sweden),1999,38(8):1011-1015. [8]Bremnes RM,Sundstrom S,Aasebo U,et al. The value of prognostic factors in small cell lung cancer:results from a randomised multicenter study with minimum 5 year follow-up[J].Lung Cancer,2003,39(3):303-313. [9]Wolf M,Holle R,Hans K,et al. Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC):the role of sex as a predictor for survival[J].Br J Cancer,1991,63(6):986-992. [10]Tamura M,Ueoka H,Kiura K,et al. Prognostic factors of small-cell lung cancer in okayama lung cancer study group trials. Acta Med Okayama,1998,52(2):105-111. [11]Allen J,Jahanzeb M. Extensive-stage small-cell lung cancer:evolution of systemic therapy and future directions[J].Clin Lung Cancer,2008,9(5):262-270.DOI:10.3816/CLC.2008.n.041. [12]Jeremic B,Shibamoto Y,Nikolic N,et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer:a randomized study[J].J Clin Oncol,1999,17(7):2092-2099. [13]Lebeau B,Chastang C,Brechot JM,et al. A randomized trial of delayed thoracic radiotherapy in complete responder patients with small-cell lung cancer[J].Chest,1993,104(3):726-733. [14]Rosenthal MA,Tattersall MHN,Fox RM,et al. Adjuvant thoracic radiotherapy in small cell lung cancer:ten-year follow-up of a randomized study[J].Lung Cancer,1991,7(4):235-341. [15]Yee D,Butts C,Reiman A,et al. Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer[J].Radiother Oncol,2012,102(2):234-238.DOI:10.1016/j.radonc.2011.08.042. [16]Slotman BJ,Faivre-Finn C, van Tinteren H,et al. Randomized trial on thoracic radiotherapy (TRT) in extensive-stage small cell lung cancer[C].Chicago:2014 ASCO Annual Meeting,2014. [17]Xia B,Chen GY,Cai XW,et al. The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer[J].Radiat Oncol,2011,6(1):50.DOI:10.1186/1748-717X-6-50. [18]Tomita N,Kodaira T,Hida T,et al. The impact of radiation dose and fractionation on outcomes for limited-stage small-cell lung cancer[J].Int J Radiat Oncol Biol Phys,2010,76(4):1121-1126.DOI:10.1016/j.ijrobp.2009.03.069.
2016, Vol. 25 
